Attention Deficit and Hyperactivity Disorder (ADHD) is one of the most prevalent psychiatric disorders in children and can also have an important impact in adults. Current research has questioned the low reliability in the methods used for the diagnosis of mental diseases, including ADHD. At the same time interesting developments in the fields of electroencephalography (EEG) and event related potentials (ERP) has improved the understanding of some of the most taxing mental disorders. The group led by Yuri Kropotov (The Brain Research Institute in St. Petersburg, Russia) developed a set of human neurophysiological biomarkers for brain functions using EEG and ERP methods. Both techniques have proven themselves in the clinical settings. The use of these tests resulted in better diagnoses, targeted treatments, and enhanced understanding of the difficulty mental disorders represent. Leading to a high satisfaction among users (psychiatrists, pediatricians, neurologists, psychologists, psychotherapists), but especially, in a better understanding of the patients’ symptomatology.
Two internationally renowned speakers in this area will be discussing these concepts in this one-day intensive workshop (offered in English language only).
Qualquer dúvida entre em contato: firstname.lastname@example.org
Morning session: 8:00-12:00
- Basics of Attention Deficit Hyperactivity Disorder (ADHD)
- Basics of developmental neurophysiology
- Developmental plasticity
- Principles of cognitive-behavioral pediatrics
- Technical aspects of EEG and ERP’s
Lunch: 12:00 – 13:00
Afternoon session: 13:30-17:30
- Interaction model for mental illness, particularly for ADHD
- Biomarker model of mental illness
- Evoked potentials and brain functions
- Biomarkers of sensitivity
- Biomarkers for executive functions
- Biomarkers of Arousal
- Biomarkers of medication
- Biomarkers for therapy and everyday strategies
|Dr. Andreas Müller, Zurich. Switzerland.||Andreas Müller is CEO of The Swiss Brain and Trauma Foundation, and has over 40 years of experience in clinical practice. Together with Yuri Kropotov developed the HBImed Biomarker neural model. This has been validated in clinical practices.|
|Dr. León Morales-Quezada, Boston. USA.||
Dr. Morales-Quezada is Associate Research Director of the Spaulding-Labuschagne Neuromodulation Center at Spaulding Rehabilitation Hospital, Harvard Medical School. Dr. Morales-Quezada is specialist in neurological and cognitive rehabilitation.